Way Towards New Life

Liver Disease Medications

Alleviare promptly facilitates Indian patients and physicians under Named Patient Programs (NPP) to access imported authorized medicines that are not locally available to them.

Get access to an unapproved drug for personal use.

Here is a list of some of the Liver Disease Medications for which we currently have a NPP in place. If you are a patient or  healthcare professional, please click below on each to access details and information.

IMJUDO (tremelimumab-actl) injection

Imjudo is a cancer medicine. It is used to treat: hepatocellular carcinoma (a type of liver cancer) in adult patients

Vistide (cidofovir injection)

Vistideis a brand-name prescription drug that’s FDA-approved to treat CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS).

VPRIV (velaglucerase alfa) for injection

Vpriv is used for the long-term treatment of patients with Gaucher disease. Gaucher disease is a rare inherited disorder, in which people do not have enough of an enzyme called glucocerebrosidase

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

Access Under Named Patient Programs

Specialty Drugs

Here is a list of some of the products for which we currently have a NPP in place. If you are a patient or  healthcare professional, please click below on each to access details and information.

XERMELO (telotristat ethyl) tablets

Xermelo is a medicine used to treat adults with severe diarrhoea associated with a condition called carcinoid syndrome.

INGREZZA (valbenazine) capsules

INGREZZA is a vesicular monoamine transporter 2 (VMAT2) inhibitor indicated for the treatment of adults with tardive dyskinesia.

TAKHZYRO (lanadelumab) for injection

TAKHZYRO contains the active substance lanadelumab. TAKHZYRO is a prescriptio medicine used in adults, and adolescents aged 12 years and older to prevent

Query Form

We would love to speak with you.
Feel free to reach out using the below details.

Access Unauthorized Medicines In India Under NPP.

What is Named-patient access programme (NPP)?

Named-patient basis access can also refer to a medicine for a specific patient or patients that is not (yet) authorised and available to them in their own country. Such medicine should or must (depending on legislation) be authorised in at least one country, from which it can be imported into the patient’s country under a Named-patient access programme (NPP).

These may be medicines that are:

  • Authorised but not yet available to be prescribed in the patient’s country.
  • Authorised and available in one country but not authorised and available in the patient’s country.
  • Discontinued in the patient’s country but not in another country.
  • In shortage in the patient’s country but not in another country.

Antibiotic

Arthritis

Diabetes

Genetics

Disorders

Hepatitis C

Hematologic Cancers

HIV/AIDS

Immunological Disorders

Liver Disease

Multiple Sclerosis

Nerver Disease

Oncology

Parkinson's Disease

Rare Disease

Soft Tissue Sarcoma

Transplant

Specialty Drugs

Get Access to an Unapproved Drug

For personal use, get access to an imported medicines (unapproved drug in India) for Liver Disease. On request, Anti-cancer medicines can be imported to following cities in India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Alleviare provides only information & in any way, does not lay any claim on these brand names &/or trademarks.